Elimination of asbestos use and asbestos‐related diseases: An unfinished story
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Asbestos is a proven human carcinogen. Asbestos‐related diseases (ARD s) typically comprise lung cancer, malignant mesothelioma, asbestosis, pleural plaques, thickening and effusion. International organizations, notably the W orld H ealth O rganization and the I nternational L abour O rganization, have repeatedly declared the need to eliminate ARD s, and have called on countries to stop using asbestos. However, the relevant national‐level indicators (e.g., incidence/mortality rates and per capita asbestos use, as well as their interrelationships) indicate that ARD s are increasing and asbestos use is continuing in the world. Lessons learned by industrialized countries in terms of policy and science have led to a growing number of countries adopting bans. In contrast, industrializing countries are faced with a myriad of forces prompting them to continue using asbestos. Full‐scale international cooperation will thus be needed, with industrialized countries sharing their experiences and technologies to enable industrializing countries to make smooth transitions to banned states and achieve the goal of eliminating ARD s.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A review of human carcinogens—Part C: metals, arsenic, dusts, and fibres
Straif, K., Benbrahim-Tallaa, L., Baan, R., Grosse, Y., Secretan, B., El Ghissassi, F., Bouvard, V., Guha, N., Freeman, C., Galichet, L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70134-2 · Cited by 924
Cited by
Treatments of asbestos containing wastes
Spasiano, D., & Pirozzi, F. (2017) · Journal of Environmental Management · doi:10.1016/j.jenvman.2017.08.038 · Cited by 119
Serum HMGB1 as a Potential Biomarker for Patients with Asbestos-Related Diseases
Ying, S., Jiang, Z., He, X., Yu, M., Chen, R., Chen, J., Ru, G., Chen, Y., Chen, W., Zhu, L., et al. (2017) · Disease Markers · doi:10.1155/2017/5756102 · Cited by 54
Bloise, A., Ricchiuti, C., Punturo, R., & Pereira, D. (2020) · Chemical Geology · doi:10.1016/j.chemgeo.2020.119896 · Cited by 46
“…the widespread use of ACMs (e.g., hospitals, schools, gyms, cinemas, industrial plants) during the peak period of asbestos consumption around 1977 (Park et al., 2012), the handling of asbestos-containing materials is still a matter of global concern (Paglietti et al., 2012; Spasiano and Pirozzi…”
BackgroundRecent progress and perspectives on the mechanisms underlying Asbestos toxicity
Kuroda, A. (2021) · Genes and Environment · doi:10.1186/s41021-021-00215-0 · Cited by 38
Metadata
- Authors
- Park, E., Takahashi, K., Jiang, Y., Movahed, M., & Kameda, T.
- Venue
- Cancer Science
- Publisher
- Wiley
- Published
- 2012-08
- Volume
- 103
- Issue
- 10
- Pages
- 1751-1755
- ISSN
- 1347-9032 (ISSN-L)
- 1349-7006
- OpenAlex
- W1970037272
- Cited by
- 44
- References
- 1
- FWCI
- 4.03
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Elimination of asbestos use and asbestos‐related diseases: An unfinished story. https://app.cochat.ai/papers/10.1111/j.1349-7006.2012.02366.x
- The paper
- Park, E., Takahashi, K., Jiang, Y., Movahed, M., & Kameda, T. (2012). Elimination of asbestos use and asbestos‐related diseases: An unfinished story. Cancer Science. https://doi.org/10.1111/j.1349-7006.2012.02366.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.